5AM Venture Management, LLC Q3 2025 Filing

Filed November 14, 2025

Portfolio Value

$273.0B

Holdings

25

Report Date

Q3 2025

Filing Type

13F-HR

All Holdings (25 positions)

#StockSharesValue% PortfolioType
1
SKYESKYE BIOSCIENCE INC
9,681,763$38.0B13.94%
2
TRDAENTRADA THERAPEUTICS INC
4,256,379$24.7B9.04%
3
PHVSPHARVARIS N V
797,600$19.9B7.29%
4
CAMPCAMP4 THERAPEUTICS CORP
5,869,091$17.6B6.45%
5
CNTACENTESSA PHARMACEUTICALS PLC
680,945$16.5B6.05%
6
VRDNVIRIDIAN THERAPEUTICS INC
736,595$15.9B5.82%
7
ELVNENLIVEN THERAPEUTICS INC
772,477$15.8B5.79%
8
EYPTEYEPOINT PHARMACEUTICALS INC
1,050,000$15.0B5.48%
9
DNTHDIANTHUS THERAPEUTICS INC
365,053$14.4B5.26%
10
TYRATYRA BIOSCIENCES INC
939,298$13.1B4.81%
11
TCE2CELLDEX THERAPEUTICS INC NEW
497,270$12.9B4.71%
12
ERASERASCA INC
5,405,404$11.8B4.32%
13
PRAXPRAXIS PRECISION MEDICINES I
170,000$9.0B3.30%
14
GHRSGH RESEARCH PLC
572,665$8.2B3.00%
15
TECXTECTONIC THERAPEUTIC INC
511,660$8.0B2.94%
16
BHVNBIOHAVEN LTD
478,972$7.2B2.63%
17
ARTVARTIVA BIOTHERAPEUTICS INC
2,353,304$6.8B2.47%
18
SRZNSURROZEN INC
310,000$4.0B1.46%
19
TARAPROTARA THERAPEUTICS INC
800,000$3.5B1.27%
20
ALECALECTOR INC
995,841$2.9B1.08%
21
SLNSILENCE THERAPEUTICS PLC
476,200$2.5B0.91%
22
AVU0ADVERUM BIOTECHNOLOGIES INC
541,666$2.5B0.90%
23
RLYBRALLYBIO CORP
3,630,724$1.8B0.66%
24
ZNTLZENTALIS PHARMACEUTICALS INC
490,000$739.9M0.27%
25
MRSNMERSANA THERAPEUTICS INC
52,200$405.1M0.15%